Alopecia areata (AA) is an autoimmune condition characterized by non-scarring patchy alopecia.e condition affects all age groups, and an early age of onset (<12 years) is associated with an increased risk of developing chronic alopecia areata (CAA) and alopecia Totalis/universalis (AT/ AU), which may lead to a poor response to therapy. 1Among all patients of AA, almost half experience disease onset within the first two decades of life, making it the most common cause of alopecia in children. 2e various available treatment options for moderate to severe AA include topical immunotherapy/ contact irritants, systemic steroids, and steroid-sparing agents like cyclosporine, azathioprine, methotrexate, and the Janus kinase inhibitors.
Dhurat et al. (Sat,) studied this question.